Galmed Pharmaceuticals Ltd. buy Wells Fargo & Company
Start price
11.12.24
/
50%
€6.40
Target price
11.12.25
€90.54
Performance (%)
-
End price
12.12.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | -1,31 % | -0,78 % | 9,15 % |
| iShares Nasdaq 100 | 1,98 % | -2,04 % | 6,57 % |
| iShares Nikkei 225® | 0,59 % | 6,71 % | 31,58 % |
| iShares S&P 500 | 1,42 % | -0,48 % | 3,62 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Wells Fargo & Company from $88.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
08.08.25
08.08.25
€56.60
08.08.26
08.08.26
-
19.09.24
19.09.24
Stopped prediction by Wells_Fargo___Compan for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
26.02.26
26.02.26
€87.99
26.02.27
26.02.27
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
07.11.25
07.11.25
€68.47
07.11.26
07.11.26
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
21.02.25
21.02.25
€88.72
21.02.26
21.02.26
-
22.02.26
22.02.26
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
06.11.24
06.11.24
€81.94
06.11.25
06.11.25
-
07.11.25
07.11.25

